Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma

• Feng Qi,
• Jian Zhang,
• Jia Li,
• Donghe Li,
• Na Gao,
• Zhuoran Qi,
• Xiuyan Kong,
• Zhijie Yu,
• Yuan Fang,
• Wenguo Cui,
• Jinglin Xia

Affiliations

Feng Qi

National Medical Center & National Clinical Research Center for Interventional Medicine. Liver Cancer Institute, Zhongshan Hospital, Fudan University

Jian Zhang

National Medical Center & National Clinical Research Center for Interventional Medicine. Liver Cancer Institute, Zhongshan Hospital, Fudan University

Jia Li

Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Donghe Li

Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University

Na Gao

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University

Zhuoran Qi

National Medical Center & National Clinical Research Center for Interventional Medicine. Liver Cancer Institute, Zhongshan Hospital, Fudan University

Xiuyan Kong

Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital of Wenzhou Medical University

Zhijie Yu

Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital of Wenzhou Medical University

Yuan Fang

Department of Liver Surgery, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Liver Cancer Institute, Zhongshan Hospital, Fudan University

Wenguo Cui

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Jinglin Xia

National Medical Center & National Clinical Research Center for Interventional Medicine. Liver Cancer Institute, Zhongshan Hospital, Fudan University